Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer

NCT00002866 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer
Neutropenia

Interventions

BIOLOGICAL: filgrastim
DRUG: docetaxel
DRUG: epirubicin hydrochloride

Sponsor

NCIC Clinical Trials Group